Sherlock Biosciences Acquires Sense Biodetection

Bionano Genomics Acquires BioDiscovery

October 12, 2021

Software

Bionano Genomics agreed to acquire BioDiscovery, a provider of NxClinical genomics analysis software, in a deal worth up to $100 million in cash and equity. The acquisition will integrate BioDiscovery's platform-agnostic analysis and reporting tools with Bionano's optical genome mapping technology to accelerate variant analysis and broaden Bionano's market reach; BioDiscovery founder Soheil Shams will join Bionano as Chief Informatics Officer.

Microbiologics Acquires SensID to Expand Diagnostic Reference Materials Portfolio

November 6, 2024

Biotechnology

Microbiologics has acquired SensID, a Rostock, Germany-based maker of reference materials and quality controls for molecular diagnostics, marking Microbiologics' first location outside the United States. The deal expands Microbiologics' capabilities into oncology and precision medicine and combines both companies' expertise to broaden diagnostic quality-control offerings for diagnostic developers and clinical labs.

Smiths Detection Acquires PathSensors

August 4, 2020

Biotechnology

Smiths Detection has completed the acquisition of PathSensors, a Baltimore-based biotechnology and environmental-testing company. The deal expands Smiths Detection's biological-detection capabilities, enhancing its ability to detect pathogens across end markets including food and agriculture safety and public health surveillance.

Standard BioTools Acquires Sengenics from Summa Equity

November 21, 2024

Biotechnology

Standard BioTools Inc. has acquired Sengenics Corporation Pte Ltd, a Summa Equity portfolio company, to broaden its proteomics and antibody‑profiling capabilities. The deal will integrate Sengenics' KREX™ immunoproteomics and i-OME™ Discovery platform with Standard BioTools' SomaScan/proteomics offerings to enhance biomarker discovery and accelerate drug development.

SD Biosensor and SJL Partners Acquire Meridian Bioscience for $1.53B

July 7, 2022

Medical Devices

A consortium led by SD Biosensor and private equity firm SJL Partners agreed to acquire Meridian Bioscience in an all-cash transaction valued at approximately $1.53 billion ( $34.00 per share). The deal will take Meridian private and is intended to accelerate SD Biosensor's entry into the U.S. in-vitro diagnostics market while leveraging Meridian's U.S. distribution network and product portfolio.

Discovery Life Sciences Acquires ReachBio Research Labs

April 11, 2023

Biotechnology

Discovery Life Sciences has acquired Seattle-based ReachBio Research Labs to expand its cell biology, toxicology and drug screening capabilities. The acquisition strengthens Discovery's preclinical development and multi-omics service offering, enabling customers to access a broader set of predictive cell-based assays for hematologic diseases, immunology, oncology and cell & gene therapy programs.